openPR Logo
Press release

Autologous Cell Therapy Market to Surpass US$ 23.7 Bn by 2024

03-16-2018 11:28 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Autologous Cell Therapy Market to Surpass US$ 23.7 Bn by 2024

Global Autologous Cell Therapy Market: Overview

Autologous cell therapy refers to infusion or transfer of human tissue or cells back to the same person for treating a diseased part. For the same purpose, stem cells are removed from the patient, harvested, cultured, and once again transplanted to the same person. The purpose of this method is to reduce the chances of rejection to the treatment by the body. Furthermore, autologous cell therapy does not even require immunosuppression. The growing number of cancer patients have triggered a significant demand for autologous cell therapy. According to the research report, the global market projected to reach a valuation of US$23.7 bn by the end of 2024 as compared to US$3.8 bn in 2015. During the forecast period of 2016 and 2024, the global market is estimated to exhibit a CAGR of 21.9%.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715
Unmet Medical Needs and Cost-effectiveness of Autologous Cell Therapy Drives Demand

The global market is expected to grow due to the huge pool of unmet medical needs for cell based therapy, growing government support for cell-based research, and rising number of technological innovations in cell based therapies. Currently, cell therapy is considered a promising technique for several conditions such as neurological, orthopedic, oncology, and a wide range of autoimmune diseases. The ability of stem cells to transform into a cartilage, tendon, bone (osteoblast), and muscle has given this market a fresh lease of life. The biggest advantages of autologous cells is the fact that it is relatively cost-effective, allows quick access to blood as it is derived from the patient, ensures easy method of production, and comes with the lowest threat of disease transfusion. All of these factors have been consistently boosting the demand for autologous cell therapy in recent years.

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=715
Supportive Government Policies across North America Favor Regional Market

Geographically, the market has been divided into Asia Pacific, North America, Europe, the Middle East and Africa, and Latin America. North America holds a dominant position in the global market and is expected to maintain its stance in the coming years as well. The strengthening health care infrastructure and supportive government policies are expected ensure high adoption of autologous cell therapy in North America in the near future. The analysts estimate that Asia Pacific will also register a robust CAGR in the coming years. The growth of this market in Asia pacific will be driven by the proliferating medical tourism industry, increasing contract research activities, and economic growth of certain developing countries such as India and China.

Enquiry for discount on this report –https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=715
Hospitals to Retain Dominance in Global Market over Forecast Period

The end users of autologous cell therapy are hospitals, research centers, and ambulatory centers. Of these, the hospitals dominated the global market in 2015 and are expected to continue its dominance till the end of 2024 as the surgical procedures continue to be on the rise across hospitals. The research report indicates that the ambulatory surgical centers segment will also expand at a significant rate in the coming years as it is known to reduce waiting time period before surgery, growing outpatient surgical procedures, high confidentiality and privacy of the data, and cost-effective procedure.

Some of the leading players operating in the global market are Major players operating in this Market are Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc.

View Report @ https://www.transparencymarketresearch.com/autologus-cell-therapy-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autologous Cell Therapy Market to Surpass US$ 23.7 Bn by 2024 here

News-ID: 981692 • Views: 142

More Releases from Transparency Market Research

Subsea Well Access System Market In-depth qualitative insights, historical data, …
Global Subsea Well Access System Market: Overview The global subsea well access system market is primarily driven by plummeting production from the oil and gas reserves together with ageing offshore fields. A quick shift toward subsea regions is the emerging trend in oil and gas production sector, marking an important divergence from the usual methods of production. Some of the subsea environment exists in most unexplored and extremely remote parts of
Nicotinic Acid Market Size, Share, Growth, Trends, and Forecast 2027
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the Nicotinic Acid Market for the 2019-2027 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the Nicotinic Acid Market over
1 – Decene Market Growth Analysis, Share, Demand By Regions 2027
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the 1 – Decene Market for the 2019-2027 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the 1 – Decene
Steep Slope Roofing Materials Market Analysis, Size, Share, Growth, Trends, and …
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the 1 – Decene Market for the 2019-2027 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the 1 – Decene

All 5 Releases


More Releases for Autologous

Autologous Matrix-induced Chondrogenesis Market: Report Scope and Market Segment …
The global autologous matrix-induced chondrogenesis (AMIC) market has been expected in a publication prepared by Transparency Market Research (TMR) to witness strategies aimed toward business expansion in developing economies. Countries such as South Africa, Mexico, China, India, and Brazil could be focused upon by AMIC players for gaining a strategic position in the market. This has been anticipated to help companies reduce their AMIC product costs supported by the hiring
Autologous Matrix-induced Chondrogenesis Market : Share and Analysis To 2025
Global Autologous Matrix-induced Chondrogenesis Market: Overview Autologous matrix-induced chondrogenesis (AMIC) refers to a type of treatment for the damage of articular cartilage. The treatment blends the application of a bi-layer collagen I/III membrane with micro fracture surgery. The treatment refers to a single step procedure that makes use of micro fracturing method and that is a well-established first line of treatment. The world AMIC market is foreseen to grow owing to the
Autologous Matrix-Induced Chondrogenesis Market Estimated to Flourish by 2024
Autologous Matrix-Induced Chondrogenesis (AMIC) is a biological treatment method to repair articular cartilage damage. AMIC therapy is a step wise process. Micro fracture surgery is followed by application of a bi-layer collagen I/III membrane. It slows down cartilage degeneration with an intent to avoid or delay partial or total joint replacement (e.g. knee replacement) surgery. The indications for AMIC includes Grade III or IV chondral lesions with lesion size of
Autologous Matrix-induced Chondrogenesis Market Research Report Forecast to 2024
The global AMIC market to rise at a CAGR of 8.6% between 2016 and 2024 to achieve a revenue valuation of US$186.38 mn by the concluding forecast year. In 2015, the market had reached a US$89.71 mn. By material, the AMIC market for collagen could attain a higher share of almost 50.0% by 2024. Calculated to develop at an 8.3% CAGR, North America has been predicted to be a highly
Autologous Cell Therapy Market : Trend, Analysis
Global Autologous Cell Therapy Market: Overview Autologous cell therapy refers to infusion or transfer of human tissue or cells back to the same person for treating a diseased part. For the same purpose, stem cells are removed from the patient, harvested, cultured, and once again transplanted to the same person. The purpose of this method is to reduce the chances of rejection to the treatment by the body. Furthermore, autologous cell
Autologous Cell Therapy Market: High Prevalence of Cancer Triggers Demand for Au …
Global Autologous Cell Therapy Market: Overview Autologous cell therapy refers to infusion or transfer of human tissue or cells back to the same person for treating a diseased part. For the same purpose, stem cells are removed from the patient, harvested, cultured, and once again transplanted to the same person. The purpose of this method is to reduce the chances of rejection to the treatment by the body. Furthermore, autologous cell